Avestar Capital LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 41.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,206 shares of the healthcare conglomerate’s stock after selling 2,992 shares during the quarter. Avestar Capital LLC’s holdings in UnitedHealth Group were worth $1,312,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently bought and sold shares of the stock. StoneX Group Inc. raised its holdings in UnitedHealth Group by 29.1% in the second quarter. StoneX Group Inc. now owns 9,761 shares of the healthcare conglomerate’s stock valued at $3,045,000 after acquiring an additional 2,201 shares in the last quarter. Flow Traders U.S. LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth $356,000. Seaview Investment Managers LLC grew its stake in shares of UnitedHealth Group by 103.6% during the second quarter. Seaview Investment Managers LLC now owns 4,437 shares of the healthcare conglomerate’s stock worth $1,384,000 after purchasing an additional 2,258 shares in the last quarter. Strategic Family Wealth Counselors L.L.C. lifted its holdings in UnitedHealth Group by 44.4% during the 2nd quarter. Strategic Family Wealth Counselors L.L.C. now owns 1,969 shares of the healthcare conglomerate’s stock worth $614,000 after buying an additional 605 shares during the last quarter. Finally, Finer Wealth Management Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $241,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on UNH shares. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Leerink Partners set a $410.00 price target on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Piper Sandler reduced their target price on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Finally, KeyCorp lifted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Seventeen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $385.54.
UnitedHealth Group Stock Down 0.9%
Shares of UnitedHealth Group stock opened at $330.61 on Friday. The company has a market cap of $299.48 billion, a P/E ratio of 17.26, a PEG ratio of 2.16 and a beta of 0.43. The firm has a fifty day moving average of $341.79 and a two-hundred day moving average of $315.89. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the business posted $7.15 earnings per share. The business’s revenue was up 12.2% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is currently 46.14%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- MarketBeat Week in Review – 12/1 – 12/5
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
